Career and Salary Survey
Execs say that career prospects are better than ever. Yet data from MM&M's annual Career and Salary Survey reveals a decline in growth.
When the Career and Salary Survey made its debut, in 1987, Eli Lilly's Prozac led the list of mass-market drug launches and AIDS therapy had taken a big step forward with the approval of GlaxoSmithKline's AZT, a year earlier.
"It's easy to 'fill open positions,'" Marchese says. "We've banned that phrase. If you do that, you're just checking boxes on a list."
Hint: it pays to be an EVP.
Average salaries are up—that's good! Salary gender disparity remains—that's bad! What other takeaways can be gleaned from the data revealed by respondents to MM&M 's annual Career & Salary Survey? Larry Dobrow gets inside the numbers
Salaries are down,the industry gender gap persists and people have their eyes peeled for better gigs. But job satisfaction remains positive and, compared with other businesses, the pay isn't half-bad. James Chase attempts to make sense of the seeming contradictions
Although job-cut announcements have become a part of daily life in the industry, average salaries have risen to an all-time high. Not only that, job satisfaction is up in pharma. However, this doesn't seem to prevent more people than ever looking to move, finds James Chase
The 26th MM&M Career & Salary Survey reports that average salaries are slightly outpacing inflation. To get the whole story, download a copy of the full report.
The job cuts haven't stopped. But here's the good news: average salaries are up, job satisfaction is holding steady, and execs seem to be valuing corporate culture over paycheck size. James Chase reports
Despite the job cuts that have darkened the pharma job market, top talent will always be in demand—and most respondents to MM&M's 25th Career & Salary Survey seem fairly content. James Chase reports
Following last year's unprecedented decreases, average salaries have bounced back to 2008 levels. Is the storm finally passing? James Chase reports on the key findings of the Career & Salary Survey 2010
Featuring hundreds of additional insights on salaries, benefits, motivations, job satisfaction, attitudes, and employment trends in the healthcare marketing sector.
Pharma companies and agencies are answering the call for bigger paychecks and better working environments as the battle for top talent heats up.
- Five things for pharma marketers to know: Wednesday, March 22, 2017
- Five things for pharma marketers to know: Monday, March 20, 2017
- Novartis aims to bring first oral asthma drug to market in two decades
- Drugmakers target severe asthma patients with biologics, but payers raise pricing issue
- Five things for pharma marketers to know: Tuesday, March 21, 2017
- 2017 Healthcare Marketers Trend Report: All the data in one place
- Infographic: What's next for the point of care market
- Drugmakers again boost DTC spending, to $5.6 billion in 2016
- Digital IDs become focus as drugmakers seek to track doctors' behavior online
- Some CME experts remain skeptical when it comes to social media